Training the next generation

MUSC student Thomas Blouin received a prestigious NCI fellowship to study how a chemical that doesn't seem to change DNA still causes cancer.

Read his story
a student and mentor work together in a cancer research lab

News

New study aims to help people quit vaping

Ben Toll and Lisa Fucito

Smoking cessation experts are starting to see more people who want help to quit vaping – but there are no FDA-approved medications to help in vaping cessation.

Benjamin Toll, Ph.D., is collaborating with Lisa Fucito, Ph.D., at Yale New Haven Health on a new study to test whether varenicline, a well-known medication for smoking cessation, could also help people to quit vaping.

Read about the study

Facebook icon Twitter icon Instagram icon LinkedIn logo icon

two cancer researchers pose in the garden

HPV Cancers

Hollings researchers uncovered data showing that women who survive cervical cancer are at greater risk of anal cancer years down the road.

a group photo in front of a linear accelerator machine

Radiation Therapy

The radiation therapy team MUSC Hollings Cancer Center Orangeburg is debuting the latest version of the True Beam linear accelerator.

Abirami Sivapiragasam consults with nurse in hallway

TNBC and Heart Disease

A clinical trial at Hollings is looking for answers to a problem that Dr. Avi Siva saw was affecting her triple negative breast cancer patients.

two women stand in a doorway prepared to cut a ceremonial ribbon made of physical therapy tape

Cancer PT

An expanded physical therapy space for cancer survivors at MUSC Hollings Cancer Center opens possibilities for patients and the program.

group photo of students and faculty members at Hollings Cancer Center

Cancer Researchers of Tomorrow

A new microcredential from Hollings Cancer Center highlights the work of future cancer researchers, who are learning both science and compassion.

Hollings Cancer Center (HCC) researcher Besim Ogretmen, Ph.D. is program coleader of Hollings Cancer Center's Developmental Cancer Therapeutics Research Program, and professor of Biochemistry and Molecular Biology at MUSC Hollings Cancer Center at the Medical University of South Carolina.

Mitochondrial Targeting

MUSC Hollings Cancer Center researchers are working on a new drug that destroys cancer cells' energy factories.

HPV public health researcher Kalyani "Kelly" Sonawane

HPV-Cancer Connection

Many people remain unaware that HPV can cause six types of cancer – and that can affect whether people choose to vaccinate.

HPV cancers public health researcher Dr. Trisha Amboree poses at Hollings Cancer Center

Cervical Cancer Screening

Counties with historically lower rates of screening for cervical cancer have higher rates of late-stage diagnosis and death.

group photo of four women

Living Fiercely

MUSC Wellness Center program helps gynecologic cancer patients to restore quality of life by addressing physical and cognitive side effects of treatment.

Read more news

“ Obviously, I’m at high risk for certain cancers, but I would rather be proactive and do the screenings. That way, if I do get cancer, I’m going to find out early rather than find out when I’m sick. ”

Carson Thomas, Hereditary Cancer Clinic patient

Read Carson's story
a smiling man stands outside in a garden

Featured video

There are 18 million cancer survivors in the U.S., including almost 300,000 in South Carolina.  

Danielle Lee is one of those survivors – twice over! She has survived both leukemia and triple negative breast cancer.  

Life is different after cancer, she says, but it’s good to be here with her family. She shared her story in honor of National Cancer Survivor Month.   

Explore the News Center

Hollings Horizons Magazine   |   Media Relations   |   Cross Talk   |   Subscribe

Visit the News Archive
Contact Us
Check out our Multimedia